Find stats on top websites
Major Markets
Proscia positions itself as the leading enterprise pathology platform, revolutionizing diagnostics and R&D through 100% digitization and advanced AI for precision medicine. They are a trusted partner for efficiency, accuracy, and innovation in healthcare and life sciences.
Customer sentiment appears to be positive, given the focus on addressing key pain points like workflow inefficiencies, data fragmentation, and the need for intuitive AI integration. The emphasis on improved diagnostic precision and accelerated R&D suggests strong alignment with customer goals.
Proscia's key value proposition lies in enabling 100% digital pathology workflows and integrating advanced AI capabilities, accelerating drug discovery, development, and diagnostics. This delivers faster, more precise results and drives efficiency across diagnostic labs and life sciences organizations.
Enterprise platform for digital pathology.
Strong focus on AI and precision medicine.
Broad interoperability and open API.
Proven track record with top pharma.
Intuitive user experience for pathologists.
Specific scanner/use limitations for AP-Dx.
No explicit pricing details provided.
Relatively new market requiring adoption.
Reliance on digital infrastructure availability.
Potential for complex integration challenges.
Growing demand for digital pathology.
Expansion into new therapeutic areas.
AI advancements creating new use cases.
Partnerships with tech and healthcare firms.
Increased remote work capabilities for labs.
Competition from established players.
Rapid technological changes in AI.
Data security and privacy concerns.
Regulatory hurdles in medical devices.
Resistance to change in traditional labs.
Proscia's primary market is the US, followed by the UK and Canada, reflecting advanced healthcare technology adoption.
United States
50% market share
United Kingdom
10% market share
Canada
8% market share
Germany
7% market share
France
5% market share
40-65 years
Male • Female
North America • Europe • Asia
30-60 years
Male • Female
North America • Europe • Asia
30-55 years
Male • Female
North America • Europe • Asia
40-65 years
Male • Female
North America • Europe • Asia
28-50 years
Male • Female
North America • Europe • Asia
Data shown in percentage (%) of usage across platforms
Create an interactive ROI calculator on Proscia's website that allows potential customers to input their lab's current metrics and see the potential return on investment from implementing Concentriq®. This will help demonstrate the tangible benefits of Proscia's platform, such as improved efficiency and faster turnaround times, directly addressing the needs of Laboratory Directors and CEOs.
Learn moreImplement a personalized onboarding experience within the Concentriq platform tailored to each user role (Pathologist, IT Admin, R&D Leader). This will showcase relevant features and benefits based on their specific needs and goals, enhancing user engagement and driving platform adoption across different buyer personas.
Learn moreDevelop comprehensive buyer's guides specifically addressing the needs of Proscia's key buyer personas: Laboratory Directors/CEOs, Pathologists, IT Teams, and Life Sciences R&D Leaders. These guides will provide detailed information on how Concentriq solves their unique challenges and delivers value, positioning Proscia as a trusted partner and thought leader.
Learn moreSign up now and unleash the power of AI for your business growth